Diagnosis and antimicrobial therapy of infections caused by polyresistant microorganisms (updated 2024)
Authors:
- V. B. BeloborodovVBV. B. Beloborodov
- N. A. ZubarevaNZN. A. Zubareva
- D. A. KamyshovaDKD. A. Kamyshova
- N. N. KlimkoNKN. N. Klimko
Open Access
- 16 April 2025
- journal article
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Messenger of ANESTHESIOLOGY AND RESUSCITATION
- Vol. 22 (2) , 149-189
Abstract
Strains of microorganisms characterized by resistance to antimicrobial drugs used in medical organizations continue to spread in most regions of the world, including Russia. This naturally affects both the effectiveness of antimicrobial therapy and the tactics of its use not only in adults but also in children. The coronavirus pandemic has highlighted the growing problems with the treatment of invasive mycoses, the selection of dosage of antibacterial agents when using sorption and dialysis therapy methods. In combination with the registration of new antibacterial drugs ABSTRACT in Russia, this necessitated the need to make adjustments to the Methodological recommendations “Diagnostics and Antimicrobial Therapy of Infections Caused by Polyresistant Strains of Microorganisms” (2nd edition), prepared by a group of leading Russian experts in 2022 [1]. The presented version was approved in December 2024 at a joint meeting of representatives of public organizations: the Russian Association of Anesthesiologists-Intensivists, the Interregional public organization “Alliance of Clinical Chemotherapists and Microbiologists”, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), the public organization “Russian Sepsis Forum”. These recommendations reflect the interdisciplinary consensus opinion on approaches to the diagnosis and antimicrobial therapy of infections caused by polyresistant microorganisms.Keywords
This publication has 67 references indexed in Scilit:
- What is New in Augmented Renal Clearance in Septic Patients?Current Infectious Disease Reports, 2023
- Antimicrobial pharmacokinetics and dosing in critically ill adults receiving prolonged intermittent renal replacement therapy: A systematic reviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- Practical considerations for individualizing drug dosing in critically ill adults receiving renal replacement therapyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing softwareIntensive Care Medicine, 2022
- Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021Intensive Care Medicine, 2021
- Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control studyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Rapid detection of OXA-48-like, KPC, NDM, and VIM carbapenemases in Enterobacterales by a new multiplex immunochromatographic testEuropean Journal of Clinical Microbiology & Infectious Diseases, 2018
- Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteriaAnnals of Hematology, 2018
- Evaluation of GeneOhm VanR and Xpert vanA/vanB molecular assays for the rapid detection of vancomycin-resistant enterococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- Risk factors for infections with multidrug‐resistant Pseudomonas aeruginosa in patients with cancerCancer, 2005